Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Symmons

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Annals of the Rheumatic Diseases|July 1, 1993
Absence of an association between HLA-DRB1*04 and rheumatoid arthritis in newly diagnosed cases from the communityW Thomson, L Pepper, A Payton, et al.
Archives of Disease in Childhood|May 13, 2006
Systematic review of effectiveness of bisphosphonates in treatment of low bone mineral density and fragility fractures in juvenile idiopathic arthritisJ Thornton, D M Ashcroft, M Z Mughal, et al.
Arthritis and Rheumatism|October 19, 1999
The influence of HLA-DRB1 alleles and rheumatoid factor on disease outcome in an inception cohort of patients with early inflammatory arthritisB Harrison, W Thomson, D Symmons, et al.
Health Technology Assessment (Winchester, England)|February 21, 2008
A systematic review of the effectiveness of strategies for reducing fracture risk in children with juvenile idiopathic arthritis with additional data on long-term risk of fracture and cost of disease managementJ Thornton, D Ashcroft, T O'Neill, et al.
Health Technology Assessment (Winchester, England)|October 5, 2006
A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modellingT J Brown, L Hooper, R A Elliott, et al.
Arthritis and Rheumatism|October 11, 2001
Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopeniaJ D Isaacs, S Greer, S Sharma, et al.
The Pharmacogenomics Journal|October 6, 2010
A genetic marker at the OLIG3/TNFAIP3 locus associates with methotrexate continuation in early inflammatory polyarthritis: results from the Norfolk Arthritis RegisterD Plant, T Farragher, E Flynn, et al.
Rheumatology (Oxford, England)|February 8, 2005
Guideline for anti-TNF-alpha therapy in psoriatic arthritisS Kyle, D Chandler, C E M Griffiths, et al.
Rheumatology (Oxford, England)|November 3, 2005
Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinical trialD Symmons, K Tricker, M Harrison, et al.
Rheumatology (Oxford, England)|April 18, 2008
Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosisJ Thornton, M Lunt, D M Ashcroft, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Annals of the Rheumatic Diseases|July 1, 1993
Absence of an association between HLA-DRB1*04 and rheumatoid arthritis in newly diagnosed cases from the communityW Thomson, L Pepper, A Payton, et al.
Archives of Disease in Childhood|May 13, 2006
Systematic review of effectiveness of bisphosphonates in treatment of low bone mineral density and fragility fractures in juvenile idiopathic arthritisJ Thornton, D M Ashcroft, M Z Mughal, et al.
Arthritis and Rheumatism|October 19, 1999
The influence of HLA-DRB1 alleles and rheumatoid factor on disease outcome in an inception cohort of patients with early inflammatory arthritisB Harrison, W Thomson, D Symmons, et al.
Health Technology Assessment (Winchester, England)|February 21, 2008
A systematic review of the effectiveness of strategies for reducing fracture risk in children with juvenile idiopathic arthritis with additional data on long-term risk of fracture and cost of disease managementJ Thornton, D Ashcroft, T O'Neill, et al.
Health Technology Assessment (Winchester, England)|October 5, 2006
A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modellingT J Brown, L Hooper, R A Elliott, et al.
Arthritis and Rheumatism|October 11, 2001
Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopeniaJ D Isaacs, S Greer, S Sharma, et al.
The Pharmacogenomics Journal|October 6, 2010
A genetic marker at the OLIG3/TNFAIP3 locus associates with methotrexate continuation in early inflammatory polyarthritis: results from the Norfolk Arthritis RegisterD Plant, T Farragher, E Flynn, et al.
Rheumatology (Oxford, England)|February 8, 2005
Guideline for anti-TNF-alpha therapy in psoriatic arthritisS Kyle, D Chandler, C E M Griffiths, et al.
Rheumatology (Oxford, England)|November 3, 2005
Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinical trialD Symmons, K Tricker, M Harrison, et al.
Rheumatology (Oxford, England)|April 18, 2008
Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosisJ Thornton, M Lunt, D M Ashcroft, et al.
Pageof 7